Jose Carlos Gómez-Tamayo

Jose Carlos Gomez-Tamayo is a Scientist in the In-silico discovery group at Johnson & Johnson Innovative Medicines. In this role, he provides comprehensive support to projects, particularly those in their early stages, as part of a dynamic team dedicated to fast-tracking hit identification to hit-to-lead. He takes on both technical and functional capacities, delivering the necessary tools and analyses to address project needs from a multidisciplinary perspective. Additionally, his work involves the development and integration of AI/ML models in the drug discovery pipeline, with a specialization in 3D binding affinity prediction and generative models.